Search Results - F/LOSS~

Glucocorticoids, inflammation and bone loss

Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series

Glucocorticoids, inflammation and bone loss

Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series

Glucocorticoids, inflammation and bone loss

Table of Contents: “…Contents: Direct & indirect effects of glucocorticoids on bone -- Management of Glucocorticoid-Induced Osteoporosis (GIOP) -- Inflammation and bone loss in back pain & rheumatoid arthritis (RA) -- Cytokines, T lymphocytes & autoimmunity in bone loss -- Sclerostin inhibition, PTH and inflammation effects on bone formation -- Anti-TNF effects on bone remodeling, BMD and fractures.…”
Get full text
Series

Syphilis : Medicine, Metaphor, and Religious Conflict in Early Modern France / by Losse, Deborah N., 1944-

Full text available:

Syphilis : Medicine, Metaphor, and Religious Conflict in Early Modern France / by Losse, Deborah N., 1944-

Full text available:

Goat Medicine and Surgery / by Harwood, David, Mueller, Karin

Table of Contents: “…Female reproductive tract diseases. Causes of foetal loss / abortion. Male reproductive tract diseases. …”
Click here to view.

Osteoporosis in men

Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series

Osteoporosis in men

Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series

Osteoporosis in men

Table of Contents: “…Contents: Epidemiology and mechanisms of bone loss in men -- Hip fractures in men -- Role of IGF-I and sex hormones in bone loss -- Bone fractures in obese/overweight men -- Review of the endocrine society guidelines on osteoporosis in men -- Assessing risk factors for osteoporosis in men -- Review of osteoporosis treatments -- Gaps in evidence base.…”
Get full text
Series

The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series

The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series

The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
Get full text
Series

Pathways regulating bone resorption

Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series

Pathways regulating bone resorption

Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series

Pathways regulating bone resorption

Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
Get full text
Series

The genetic basis of kidney cancer

Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

The genetic basis of kidney cancer

Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

The genetic basis of kidney cancer

Table of Contents: “…Contents: Renal carcinoma -- Stage I , Stage IV Kidney Cancer -- Human renal epithelial neoplasms -- Loss of alleles in Renal Cell Carcinoma -- Mapping the minimal 3p loss region in Clear Cell Renal Carcinoma -- Studying cancer families to identify renal carcinoma genes -- Identification of kidney cancer genes -- Inherited forms of renal carcinoma -- Clear cell Renal Carcinoma: von Hippel Lindau (VHL) -- VHL gene -- VHL gene localization map -- Germline VHL mutations -- Papillary Renal Carcinoma -- Mouse studies of VHL gene -- VHL gene function -- HIFα -- Downstream effects of VHL mutation -- Targeting VHL/HIF in Clear Cell RCC -- TCGA Clear Cell Kidney Cancer -- Intratumor heterogeneity -- Warburg effect in Clear Cell Kidney Cancer -- Non-Clear Cell RCC -- Locally advanced Kidney Cancer -- Hereditary Papillary Renal Carcinoma (HPRC) -- Inherited Renal Carcinoma -- Type 1 Papillary Renal Carcinoma -- Penetrance of MET mutation H1210R -- MET gene: Type 1 Papillary RCC -- Location of the HPRC gene -- HPRC: Activating mutations in the Tyrosine Kinase domain of MET -- Location of MET mutations in the HPRC patients -- Targeting MET RCC gene pathway -- Potential small molecule target: MET Tyrosine Kinase inhibition -- Foretinib: Dual VEGFR and MET Inhibitor -- MiT Kidney Cancer TFE3, TFEB, MITF -- UOK124, Papillary Kidney Cancer -- UOK124, UOK120, UOK 146 & TFE3 Kidney Cancer -- Inherited Renal Carcinoma Birt-Hogg-Dubé (BHD) -- Birt Hogg Dubé cutaneous manifestations -- Kidney tumors in BHD -- BHD renal tumor pathology -- BHD lung cysts -- Identification of the BHD Gene -- Cutaneous Fibrofolliculomas -- BHD Gene: Chromophobe RCC -- BHD Gene Locus: Chromosome 17 -- BHD Protein Sequence -- FLCN Mutation Spectrum -- Therapeutic Approach: What Kind of Gene is FLCN? …”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

Gut microbiota, chronic inflammation and metabolic syndrome

Table of Contents: “…Contents: Managing intestinal bacteria -- Toll-like receptors -- Flagellin -- Enhancing inflammation through blockade of a pro-inflammatory signaling pathway -- T5KO mice -- Embryo transfer -- Loss of TLR5 and alteration of the composition of the gut microbiota -- Possible role of gut microbiota in metabolic syndrome and relevance in humans -- The human gut microbiota in the last 50-100 years -- Dietary disturbance of the gut microbiota & metabolic syndrome.…”
Get full text
Series

Gut microbiota, chronic inflammation and metabolic syndrome

Table of Contents: “…Contents: Managing intestinal bacteria -- Toll-like receptors -- Flagellin -- Enhancing inflammation through blockade of a pro-inflammatory signaling pathway -- T5KO mice -- Embryo transfer -- Loss of TLR5 and alteration of the composition of the gut microbiota -- Possible role of gut microbiota in metabolic syndrome and relevance in humans -- The human gut microbiota in the last 50-100 years -- Dietary disturbance of the gut microbiota & metabolic syndrome.…”
Get full text
Series